vs
Side-by-side financial comparison of Clarus Corp (CLAR) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $65.4M, roughly 1.2× Clarus Corp). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -8.4%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $11.6M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -2.9%).
Clarus Corp is a global designer, manufacturer, and distributor of high-performance outdoor recreation, climbing, camping, and lifestyle products. It manages a portfolio of leading consumer brands, serving outdoor enthusiasts, professional athletes, and retail partners across North America, Europe, and the Asia-Pacific region, with a focus on innovative, durable gear for active lifestyles.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
CLAR vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $65.4M | $75.5M |
| Net Profit | $-31.3M | — |
| Gross Margin | 27.7% | 69.3% |
| Operating Margin | -59.6% | 22.7% |
| Net Margin | -47.8% | — |
| Revenue YoY | -8.4% | 27.7% |
| Net Profit YoY | 52.3% | — |
| EPS (diluted) | $-0.81 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $65.4M | $75.5M | ||
| Q3 25 | $69.3M | $54.5M | ||
| Q2 25 | $55.2M | $52.4M | ||
| Q1 25 | $60.4M | $46.0M | ||
| Q4 24 | $71.4M | $59.1M | ||
| Q3 24 | $67.1M | $80.5M | ||
| Q2 24 | $56.5M | $47.1M | ||
| Q1 24 | $69.3M | $43.8M |
| Q4 25 | $-31.3M | — | ||
| Q3 25 | $-1.6M | $8.8M | ||
| Q2 25 | $-8.4M | $5.9M | ||
| Q1 25 | $-5.2M | $3.0M | ||
| Q4 24 | $-65.5M | — | ||
| Q3 24 | $-3.2M | $20.3M | ||
| Q2 24 | $-5.5M | $-4.5M | ||
| Q1 24 | $21.9M | $-4.8M |
| Q4 25 | 27.7% | 69.3% | ||
| Q3 25 | 35.1% | 77.7% | ||
| Q2 25 | 35.6% | 76.5% | ||
| Q1 25 | 34.4% | 77.1% | ||
| Q4 24 | 33.4% | 76.4% | ||
| Q3 24 | 35.0% | 63.9% | ||
| Q2 24 | 36.1% | 77.4% | ||
| Q1 24 | 35.9% | 75.5% |
| Q4 25 | -59.6% | 22.7% | ||
| Q3 25 | -4.4% | 17.6% | ||
| Q2 25 | -19.7% | 12.7% | ||
| Q1 25 | -11.2% | 8.7% | ||
| Q4 24 | -70.2% | 22.6% | ||
| Q3 24 | -8.0% | 27.4% | ||
| Q2 24 | -14.4% | -4.6% | ||
| Q1 24 | -9.8% | -5.3% |
| Q4 25 | -47.8% | — | ||
| Q3 25 | -2.3% | 16.2% | ||
| Q2 25 | -15.3% | 11.2% | ||
| Q1 25 | -8.7% | 6.5% | ||
| Q4 24 | -91.8% | — | ||
| Q3 24 | -4.7% | 25.2% | ||
| Q2 24 | -9.7% | -9.6% | ||
| Q1 24 | 31.6% | -11.0% |
| Q4 25 | $-0.81 | $0.26 | ||
| Q3 25 | $-0.04 | $0.17 | ||
| Q2 25 | $-0.22 | $0.12 | ||
| Q1 25 | $-0.14 | $0.06 | ||
| Q4 24 | $-1.72 | $0.40 | ||
| Q3 24 | $-0.08 | $0.41 | ||
| Q2 24 | $-0.14 | $-0.09 | ||
| Q1 24 | $0.57 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.7M | $97.5M |
| Total DebtLower is stronger | $0 | $22.7M |
| Stockholders' EquityBook value | $196.4M | $130.3M |
| Total Assets | $249.0M | $216.3M |
| Debt / EquityLower = less leverage | 0.00× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.7M | $97.5M | ||
| Q3 25 | $29.5M | $94.4M | ||
| Q2 25 | $28.5M | $96.0M | ||
| Q1 25 | $41.3M | $93.2M | ||
| Q4 24 | $45.4M | $101.0M | ||
| Q3 24 | $36.4M | $96.7M | ||
| Q2 24 | $46.2M | $96.8M | ||
| Q1 24 | $47.5M | $107.2M |
| Q4 25 | $0 | $22.7M | ||
| Q3 25 | $2.0M | $34.0M | ||
| Q2 25 | $1.9M | $45.3M | ||
| Q1 25 | $1.9M | $56.7M | ||
| Q4 24 | $1.9M | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | $37.0K | $102.0M |
| Q4 25 | $196.4M | $130.3M | ||
| Q3 25 | $225.8M | $115.3M | ||
| Q2 25 | $225.1M | $104.7M | ||
| Q1 25 | $229.3M | $97.1M | ||
| Q4 24 | $233.1M | $92.1M | ||
| Q3 24 | $308.5M | $71.1M | ||
| Q2 24 | $307.3M | $48.5M | ||
| Q1 24 | $310.4M | $51.0M |
| Q4 25 | $249.0M | $216.3M | ||
| Q3 25 | $283.1M | $202.9M | ||
| Q2 25 | $286.5M | $194.9M | ||
| Q1 25 | $292.8M | $196.2M | ||
| Q4 24 | $294.1M | $213.3M | ||
| Q3 24 | $375.3M | $220.7M | ||
| Q2 24 | $369.4M | $205.0M | ||
| Q1 24 | $377.0M | $214.1M |
| Q4 25 | 0.00× | 0.17× | ||
| Q3 25 | 0.01× | 0.30× | ||
| Q2 25 | 0.01× | 0.43× | ||
| Q1 25 | 0.01× | 0.58× | ||
| Q4 24 | 0.01× | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | 0.00× | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.5M | $14.4M |
| Free Cash FlowOCF − Capex | $11.6M | $14.4M |
| FCF MarginFCF / Revenue | 17.7% | 19.1% |
| Capex IntensityCapex / Revenue | 1.4% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-9.9M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.5M | $14.4M | ||
| Q3 25 | $-5.7M | $9.7M | ||
| Q2 25 | $-9.4M | $14.1M | ||
| Q1 25 | $-2.1M | $3.6M | ||
| Q4 24 | $16.6M | $15.6M | ||
| Q3 24 | $-8.3M | $11.0M | ||
| Q2 24 | $834.0K | $1.0M | ||
| Q1 24 | $-16.4M | $11.2M |
| Q4 25 | $11.6M | $14.4M | ||
| Q3 25 | $-7.0M | $9.7M | ||
| Q2 25 | $-11.3M | $14.1M | ||
| Q1 25 | $-3.3M | $3.6M | ||
| Q4 24 | $14.4M | $15.6M | ||
| Q3 24 | $-9.4M | $11.0M | ||
| Q2 24 | $-744.0K | $1.0M | ||
| Q1 24 | $-18.3M | — |
| Q4 25 | 17.7% | 19.1% | ||
| Q3 25 | -10.0% | 17.7% | ||
| Q2 25 | -20.4% | 26.8% | ||
| Q1 25 | -5.4% | 7.7% | ||
| Q4 24 | 20.1% | 26.4% | ||
| Q3 24 | -14.0% | 13.7% | ||
| Q2 24 | -1.3% | 2.1% | ||
| Q1 24 | -26.3% | — |
| Q4 25 | 1.4% | 0.0% | ||
| Q3 25 | 1.8% | 0.0% | ||
| Q2 25 | 3.4% | 0.0% | ||
| Q1 25 | 2.0% | 0.1% | ||
| Q4 24 | 3.1% | 0.0% | ||
| Q3 24 | 1.6% | 0.0% | ||
| Q2 24 | 2.8% | 0.0% | ||
| Q1 24 | 2.7% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.75× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLAR
| Other | $37.1M | 57% |
| Outdoor Segment | $25.3M | 39% |
| Adventure Segment | $3.0M | 5% |
PBYI
Segment breakdown not available.
